The goal of einocle is to renew the understanding of diseases that are difficult to diagnose and treat, such as rare incurable diseases or cancer, based on single-cell multi-omics analysis, and to develop novel diagnostic and therapeutic methods that directly benefit patients.

To this end, we are building our own database for single-cell genome multi-omics analysis of clinical patients suffering from various diseases at home and abroad. In addition, we are developing a high-efficiency, low-cost next-generation single-cell pre-processing platform and an AI-based advanced bioinformatics pipeline that can quickly and effectively analyze clinical data.